Results

Total Results: 153 records

Showing results for "central nervous".

141. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - Belimumab has not been evaluated in patients with severe active lupus nephritis or severe active central … nervous system lupus.

142. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Response Although the draft report of the HHS Task Force on Pain Management is referenced, its central … First of all, pain is a very complex phenomenon of the nervous system.

143. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - findings affected patient satisfaction, patient anxiety levels, or other outcome measures that may be of central … Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case

144. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - last as long as 17 days and to require as many as 128 doses of 90 mcg/kg over that time period.6’ 7 Central … nervous system bleeds in patients with hemophilia with inhibitors are treated most often for 14-21

145. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - • The Cochrane Central Register of Controlled Trials. … Sources of citations Source Number of citations MEDLINE® 1078 Cochrane Central Register of Controlled … erythematous rash, rhinitis, sinusitis, vertigo, flushing, cold hands/feet, adverse events related to the nervous

146. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - , and marketing of major therapeutic categories - Cardiovascular, Oncology, Pain & Inflammation, Central … Nervous System, and Infectious Disease X X X X X X X UroToday 1, 2 Online newsletter that aggregates

147. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - , and marketing of major therapeutic categories - Cardiovascular, Oncology, Pain & Inflammation, Central … Nervous System, and Infectious Disease X X X X X X X UroToday 1, 2 Online newsletter that aggregates

148. Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
     July 08, 2015 - Preoperative fascia iliaca compartment block for positioning patients with hip fractures for central … nervous blockade: a randomized trial.

149. Future Research Needs for Noncyclic Chronic Pelvic Pain Therapies for Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
     January 01, 2015 - 285 pounds · Hyponatremia, as determined by blood test results Investigation and Treatment of Central … Nervous System Dysfunction in Chronic Pelvic Pain, United States 5R21DK081773-03 Spaulding

150. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - Cardiac safety of central nervous system stimulants in children and adolescents with attention- deficit

151. Stakeholder-Engagement-Benefits White-Paper (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement-benefits_white-paper.pdf
     March 01, 2014 - Brett et al., 201019 United Kingdom “Patient and public involvement has become a central tenet of … “Perhaps [stakeholders] not being there in the same way I’d sort of feel nervous about the impact it

152. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system

153. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - An update on central nervous system stimulant formulations in children and adolescents with attention